EGFL7 - EGF like domain multiple 7 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100511434
EGFL7 Products (10)
| mRNA | Protein | Name |
|---|---|---|
| XM_021081043.1 | XP_020936702.1 | epidermal growth factor-like protein 7 isoform X3 |
| XM_021081039.1 | XP_020936698.1 | epidermal growth factor-like protein 7 isoform X1 |
| XM_021081042.1 | XP_020936701.1 | epidermal growth factor-like protein 7 isoform X3 |
| XM_021081038.1 | XP_020936697.1 | epidermal growth factor-like protein 7 isoform X1 |
| XM_021081044.1 | XP_020936703.1 | epidermal growth factor-like protein 7 isoform X3 |
| XM_021081046.1 | XP_020936705.1 | epidermal growth factor-like protein 7 isoform X3 |
| XM_005652718.3 | XP_005652775.1 | epidermal growth factor-like protein 7 isoform X3 |
| XM_021081040.1 | XP_020936699.1 | epidermal growth factor-like protein 7 isoform X1 |
| XM_021081045.1 | XP_020936704.1 | epidermal growth factor-like protein 7 isoform X3 |
| XM_021081041.1 | XP_020936700.1 | epidermal growth factor-like protein 7 isoform X2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
epidermal growth factor-like protein 7 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99215 | Parsatuzumab | Modulator | 97.94% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS04206 | EGFL7 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18061 | Egfl7 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24536 | Egfl7 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service